Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable
development over recent decades. However, this field is currently in a state of flux toward …

Clinically, cancer drug resistance to chemotherapy, targeted therapy or immunotherapy
remains the main impediment towards curative cancer therapy, which leads directly to …

Nanotechnology carriers have become common in pharmaceutical products because of
their benefits to drug delivery, including reduced toxicities and improved efficacy of active …

Introduction Currently, cancer immunotherapy is widely used as a groundbreaking method
that can completely cure advanced cancers. However, this new immunotherapy has the …

Photothermal therapy is a promising treating method for cancers since it is safe and easily
controllable. Black phosphorus (BP) nanosheets have drawn tremendous attention as a …

The processing of endogenous tumour antigen peptides was essential for anti-tumour
immunity in the tumour microenvironment. A high degree of Endogenous tumour antigen …

Introduction Nasopharyngeal cancer (NPC) is a complex cancer due to its unique genomic
features and association with the Epstein–Barr virus (EBV). Despite therapeutic …

A great deal of progress has been made on understanding nasopharyngeal cancer in recent
decades. Genomic, transcriptomic, and proteomic studies have enabled us to gain a deeper …

Introduction EBV infection in nasopharyngeal cancer ensued in latent infection mode. In this
latent infection various EBV oncoproteins such as EBNA1 and LMP1 was expressed. EBV …

Günümüzde ileri evre kanserlerin tedavisindeki güçlükler henüz aşılamamıştır. Kemoterapi
ve radyoterapdeki ilerlemelere rağmen, geleneksel kanser tedavisi, tümör ilerlemesini …